Centerpoint Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
50
﹤0.01% 428
2026
Q1
$1K Buy
+50
New +$428 ﹤0.01% 387
2021
Q2
Sell
-100
Closed -$1K 301
2021
Q1
$1K Hold
100
﹤0.01% 256
2020
Q4
$1K Hold
100
﹤0.01% 237
2020
Q3
$0 Hold
100
﹤0.01% 267
2020
Q2
$0 Hold
100
﹤0.01% 293
2020
Q1
$0 Hold
100
﹤0.01% 277
2019
Q4
$1K Hold
100
﹤0.01% 261
2019
Q3
$1K Hold
100
﹤0.01% 262
2019
Q2
$1K Hold
100
﹤0.01% 254
2019
Q1
$1K Hold
100
﹤0.01% 247
2018
Q4
$1K Hold
100
﹤0.01% 242
2018
Q3
$2K Hold
100
﹤0.01% 218
2018
Q2
$2K Hold
100
﹤0.01% 318
2018
Q1
$2K Hold
100
﹤0.01% 214
2017
Q4
$2K Buy
+100
New +$2.07K ﹤0.01% 178

Other funds holding PTEN

Centerpoint Advisors's PTEN Position: Q2 2026 in Review

Centerpoint Advisors held its Patterson-UTI (PTEN) position steady in Q2 2026 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Centerpoint Advisors first reported a position in PTEN in Q4 2017 and has held it in 16 quarters since. The position peaked at $2K in Q3 2018. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Centerpoint Advisors held 50 shares of Patterson-UTI worth $0 as of Q2 2026.
  • Centerpoint Advisors left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #428 holding.
  • Centerpoint Advisors first reported a position in Patterson-UTI in Q4 2017 and has held it in 16 quarters since.
  • Centerpoint Advisors's Patterson-UTI position peaked at $2K in Q3 2018.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.